USANA Health Sciences USNA Americas and Europe — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's americas and europe — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's americas and europe — net sales?
- USANA Health Sciences (USNA) reported americas and europe — net sales of $80.87M in Q1 2026.
- How has USANA Health Sciences's americas and europe — net sales changed year-over-year?
- USANA Health Sciences's americas and europe — net sales increased by 6.2% year-over-year, from $76.13M to $80.87M.
- What is the long-term trend for USANA Health Sciences's americas and europe — net sales?
- Over 4 years (2021 to 2025), USANA Health Sciences's americas and europe — net sales has grown at a 7.5% compound annual growth rate (CAGR), from $223.27M to $298.09M.
- What does americas and europe — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and personal-care products within the Americas and Europe geographic regions. It serves as a key indicator of the company's market penetration and consumer demand in these specific territories through its direct selling business model. Monitoring this figure helps investors assess the regional performance and growth trajectory of the company's international operations.